Multiple Sourcing Framework Contracts to Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines
This call for tenders aims to accelerate the development of next-generation influenza vaccines that can be produced in rapidly scalable manufacturing platforms (e.g., nucleic acid approaches, scalable eukaryotic or bacterial cell culture, plants, or in vitro transcription). The vaccines should support novel administrat...
Angebotsfrist:30. April 2026
Typ:Ausschreibung
Ohne Kreditkarte · Sofortiger Zugang
Inhalt auf einen Blick
This call for tenders aims to accelerate the development of next-generation influenza vaccines that can be produced in rapidly scalable manufacturing platforms (e.g., nucleic acid approaches, scalable eukaryotic or bacterial cell culture, plants, or in vitro transcription). The vaccines should support novel administration routes (e.g.,...
- Ausschreibungstyp: Ausschreibung
- Auftraggeber: Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
- Veröffentlicht: 02. März 2026
- Frist: 30. April 2026
- Thema: Klinische Studien
Ausschreibungsbeschreibung
This call for tenders aims to accelerate the development of next-generation influenza vaccines that can be produced in rapidly scalable manufacturing platforms (e.g., nucleic acid approaches, scalable eukaryotic or bacterial cell culture, plants, or in vitro transcription). The vaccines should support novel administration routes (e.g., nasal, oral, or microneedle patches), confer mucosal immunity, target potentially pandemic influenza A viruses, be rapidly adaptable to pandemic strains, provide protection across influenza subtypes or alpha-influenza viruses, and/or possess intrinsic immunogenicity without adjuvants. The call will be implemented through a competitive phased development under Pre-Commercial Procurement.
Weiterführende Details
Nach Registrierung stehen Unterlagen, Fristen und Hinweise zur Einreichung strukturiert bereit.